Stockhub

TaiwanJ Pharmaceuticals Co., Ltd.: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

26 September 2022

  • curprev 05:0805:08, 26 September 2022‎ 95.149.241.133 talk‎ 728 bytes +728‎ Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == TaiwanJ Pharmaceuticals Co., Ltd., a specialty pharmaceutical company, develops and commercializes small molecules for chronic organ inflammation of metabolic, autoimmune, and infectious etiologies in Taiwan. The company also develops JKB-122 and JKB-121; and novel chemical entities for therapy to address chronic liver diseases and allergy/asthma. Its products target various diseases that include liver inflammation/liver fi..." Tag: Visual edit: Switched
Retrieved from ‘https://stockhub.co/research/TaiwanJ_Pharmaceuticals_Co.,_Ltd.’